Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques-Reference-Cited by-同舟云学术

Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques

Published:2007-02 Issue:1 Volume:358 Page:69-78
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Ferrantelli Flavia,Buckley Kathleen A.,Rasmussen Robert A.,Chalmers Alistair,Wang Tao,Li Pei-Lin,Williams Alison L.,Hofmann-Lehmann Regina,Montefiori David C.,Cavacini Lisa A.,Katinger Hermann,Stiegler Gabriela,Anderson Daniel C.,McClure Harold M.,Ruprecht Ruth M.

Publisher

Elsevier BV

Subject

Virology

Reference44 articles.

1. A phase I trial with two human monoclonal antibodies (hMAb2F5, 2G12) against HIV-1;Armbruster;AIDS,2002

2. Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12;Armbruster;J. Antimicrob. Chemother.,2004

3. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection;Baba;Nat. Med.,2000

4. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1;Binley;J. Virol.,1997

5. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies;Binley;J. Virol.,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 neutralizing antibodies provide sterilizing immunity by blocking infection of the first cells;Cell Reports Medicine;2023-10

2. Continuous HIV-1 Escape from Autologous Neutralization and Development of Cross-Reactive Antibody Responses Characterizes Slow Disease Progression of Children;Vaccines;2021-03-14

3. Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity;Nature Communications;2020-01-07

4. Increasing the Clinical Potential and Applications of Anti-HIV Antibodies;Frontiers in Immunology;2017-11-28

5. The first 24 h;Current Opinion in HIV and AIDS;2016-11